What are the potential treatment implications of white-coat hypertension, masked hypertension, the white-coat effect, and masked uncontrolled hypertension?
Antihypertensive medication initiation and intensification may be considered for patients with substantial masked hypertension and masked uncontrolled hypertension, respectively, whereas for those with substantial white-coat hypertension and the white-coat effect the choice may be made to defer initiation and defer intensification of antihypertensive medication, respectively, especially in individuals with symptoms associated with documented out-of-office hypotension.